ANNX
Annexon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.23
+1.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.31x
- Price / sales
- —
- Price / cash flow
- -4.15x
Enterprise value
- Enterprise value
- $617.3M
- EV / sales
- —
- EV / EBITDA
- -3.09x
- EV / EBIT
- -2.93x
- Market cap
- $801.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026